Trans-caval aspiration artherectomy/thrombectomy of large mobile plaques and thrombi in aortic arch and descending aorta

Catheter Cardiovasc Interv. 2023 Jan;101(1):164-169. doi: 10.1002/ccd.30491. Epub 2022 Nov 15.

Abstract

Aspiration thrombectomy with the AngioVac is approved for percutaneous removal of thrombus in the venous system. While not approved for aspiration of thrombus or other mass in the left heart or arterial system, it has been used in that setting. Patients with left heart or arterial mass are often deemed unfavorable for surgery and treated conservatively. This may not be the best option for all patients, as some may have lesions that represent a short-term increased risk of complications, for which intervention and aspiration could be considered reasonable. Unfortunately, femoral arteries sizes often cannot accommodate the Angiovac current aspiration cannula dimensions. Here, we demonstrated trans-caval approach for aspiration thrombectomy of extensive aortic mobile plaque and thrombus.

Keywords: AngioVac; aortic artherectomy; aortic artheroma; aspiration; embolic stroke; stroke; stroke prevention; transcaval.

Publication types

  • Case Reports

MeSH terms

  • Aorta, Thoracic / diagnostic imaging
  • Aorta, Thoracic / surgery
  • Humans
  • Plaque, Atherosclerotic*
  • Thrombectomy / adverse effects
  • Thrombosis* / diagnostic imaging
  • Thrombosis* / etiology
  • Thrombosis* / surgery
  • Treatment Outcome